Clinical Trial Detail

NCT ID NCT02257619
Title Study of INCB039110 in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Incyte Corporation
Indications

lung non-small cell carcinoma

Therapies

Docetaxel

Itacitinib

Age Groups: adult

No variant requirements are available.